1)Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group : Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 : 19-25, 2004
2)水沼英樹,他 : 本邦における多嚢胞性卵巣症候群の新しい診断基準の設定に関する小委員会(平成17年度〜平成18年度)検討結果報告.日産婦誌59 : 868-886, 2007
3)Goldzieher JW : Polycystic ovarian disease. Fertil Steril 35 : 371-394, 1981
4)Azziz R, et al : The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome : the complete task force report. Fertil Steril 91 : 456-488, 2009
5)Lim S, et al : Overweight, obesity and central obesity in women with polycystic ovary syndrome : a systematic review and meta-analysis. Hum Reprod Update 18 : 618-637, 2012
6)Dewailly D, et al : Definition and significance of polycystic ovarian morphology : a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update 20 : 334-352, 2014
7)吉村泰典 : 委員会報告のうち統一見解とした事項.日産婦誌59 : 1131, 2007
8)Iwasa T, et al : Reproducibility of luteinizing hormone hypersecretion in different phases of the menstrual cycle in polycystic ovary syndrome. J Obstet Gynaecol Res 35 : 514-519, 2009
9)松崎利也 : 女性における各種ホルモンの基準値と解釈.青野敏博,他(編著): 産婦人科ベッドサイドマニュアル第7版.医学書院,2018
10)柳原里江,他 : 多囊胞性卵巣症候群の診断に必要な互換性の高いLH,LH/FSH比のカットオフ値の設定に関する研究.日産婦誌73(臨時増刊号) : 270, 2021
11)Mitwally MF, et al : Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 75 : 305-309, 2001
12)Legro RS, et al : Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med 371 : 119-129, 2014
13)Amer SA, et al : Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome. Hum Reprod 32 : 1631-1638, 2017
14)Franik S, et al : Aromatase inhibitors(letrozole) for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev 5 : CD010287, 2018
15)Wang R, et al : First-line ovulation induction for polycystic ovary syndrome : an individual participant data meta-analysis. Hum Reprod Update 25 : 717-732, 2019
16)Teede H, et al : International evidence-based guideline for the assessment and management of Polycystic Ovary Syndrome 2018. 2018 http://www.monash.edu/__data/assets/pdf_file/0004/1412644/PCOS_Evidence-Based-Guidelines_20181009.pdf
17)小池俊光,他 : クロミフェン抵抗性の無排卵不妊婦人に対するアロマターゼインヒビター(レトロゾール)を用いた排卵誘発の試み.日本受精着床医学会雑誌22 : 177-180, 2005
18)Tulandi T, et al : Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril 85 : 1761-1765, 2006
19)Pundir J, et al : Risk of foetal harm with letrozole use in fertility treatment : a systematic review and meta-analysis. Hum Reprod Update 27 : 474-485, 2021
20)Tatsumi T, et al : No increased risk of major congenital anomalies or adverse pregnancy or neonatal outcomes following letrozole use in assisted reproductive technology. Hum Reprod 32 : 125-132, 2017
21)Mejia RB, et al : A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome. Fertil Steril 111 : 571-578, 2019
22)久保田俊郎,他 : 「本邦における多嚢胞性卵巣症候群の治療法に関する治療指針作成のための小委員会」報告.日産婦誌61 : 902-912, 2009